Cycurion, Inc.CYCU
Information Technology · Software & Services · NASDAQ · United States
Cycurion, Inc. is an AI-driven cybersecurity and public sector technology services company headquartered in McLean, Virginia. The company provides identity-centric cybersecurity, network security, cloud management, and AI-powered IT infrastructure services to government agencies, healthcare organizations, and enterprises. Cycurion also offers program management, business continuity, and technology staffing solutions for the public sector.
Key ratios
FCF / Sales
-79.9%TTM
2025
-79.9%2024
-7.7%2023
-10.3%
Net margin
-156.4%TTM
2025
-156.4%2024
6.9%2023
-10.8%
ROA
-24.5%TTM
2025
-24.5%2024
6.5%2023
1.1%
ROE
-244.1%TTM
2025
-244.1%2024
28.2%2023
-40.9%
Revenue growth
-14.8%TTM
2025
-14.8%2024
-8.2%2023
16.6%
Recent news
Cycurion Announces Approximately $800,000 in Annual Contract Spend
Cycurion: 1-for-8 Reverse Split Backed by Stronger Fundamentals
Cycurion, Inc. Announces Reverse Stock Split Effective August 28, 2026
Cycurion Extends Patent Protection on VuLink®, the Cross-Activation Technology That Automatically Records and Syncs Every Camera on Scene, Never Missing an Event
Cycurion Board Authorizes $500,000 Share Repurchase Program, Citing Meaningful Undervaluation
Cycurion Beats Consensus on Revenue and EPS; Gross Margin Improves Nearly 5x as Company Positions for Stronger Second Half
Cycurion Confirms August 20 Nasdaq Hearing Date; Common Stock Continues Trading on Nasdaq
Cycurion Announces a Warrant Inducement Transaction for $4.5 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
Cycurion Lands Largest Contract in Company History: $54.6 Million 10-Year Award with Top-5 Global Consulting Firm
Cycurion, Inc. Announces Scheduled Nasdaq Listing Hearing and Reaffirms Commitment to Maintaining Nasdaq Listing
Track CYCU in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer